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H E A L T H  A N D  M E D I C I N E
Pathological processes in aqueous humor due to iris 
atrophy predispose to early corneal graft failure 
in humans and mice
Takefumi Yamaguchi1,2*, Kazunari Higa1,2, Yukari Yagi-Yaguchi1,2, Koji Ueda3, Hisashi Noma4, 
Shinsuke Shibata5, Toshihiro Nagai5, Daisuke Tomida1, Ririko Yasu-Mimura1,2,  
Osama Ibrahim1,2, Ryo Matoba6, Kazuo Tsubota1,2, Pedram Hamrah7,8, Jun Yamada9, 
Kohsuke Kanekura10*, Jun Shimazaki1,2
Corneal endothelial cell (CEnC) loss after corneal transplantation is the major cause of graft failure and remains a 
clinically relevant challenge to overcome. Accumulated knowledge derived from long-term clinical outcomes 
suggested that elevated protein levels in the aqueous humor are associated with CEnC loss. However, the full 
spectrum of driver proteins and molecular processes remains to be determined. Here, we defined the somatic 
microenvironmental landscape and cellular response across human aqueous humor in samples with poor corneal 
transplantation clinical outcomes using multiomics analyses and clarified specific driver alterations, including 
complement activation and disturbed energy homeostasis. These driver alterations were also confirmed in aqueous 
humor from a novel murine model that spontaneously develops iris atrophy, leading to CEnC loss. The application 
of the integrative multiomics performed in human samples to the novel murine model will help the development 
of therapeutic modalities for patients with CEnC loss after corneal transplantation.
INTRODUCTION
Corneal endothelial cells (CEnCs) form a monolayer of hexagonal 
cells located in the posterior surface of the cornea. CEnCs have a 
pump/barrier function and maintain corneal transparency. They 
are arrested in a postmitotic state and have a minimal proliferative 
capacity in vivo (1). CEnCs have a unique property, compensating 
for cell loss by cell enlargement and migration instead of proliferation 
and wound healing (2). In the human cornea, corneal endothelial 
cell density (CECD) never increases but rather decreases with age at 
a rate of 0.5% per year (3). This reduction is exacerbated to a rate of 
2.6 to 7.8% under pathological conditions, leading to CEnC dys-
function and development of bullous keratopathy (4). CEnC dys-
function is the leading cause of corneal transplantation, occupying 
for 39% of all corneal transplantation cases in the United States and 
accounting for 180,000 patients per year worldwide. Graft survival 
rate in low-risk eye conditions, such as keratoconus, exceeds 90% at 
10 years after transplantation. In contrast, corneal transplantation 
graft survival for bullous keratopathy treatment is approximately 30 
to 55% at 5 years and less than 20 to 40% at 10 years (5). Corneal 
endothelial decompensation due to postoperative CEnC loss is the 
primary cause of graft failure (29 to 49%), followed by graft rejection 
(21 to 27%) (6). Thus, CEnC loss after corneal transplantation 
remains one of the most important clinical challenges to be addressed 
by ophthalmologists.
CECD decrease rates differ among patients, with some exhibiting 
rapid CECD decrease after corneal transplantation. Recently, we 
noticed a rapid postoperative CECD decrease in patient’s eyes with 
severe preexisting iris atrophy after corneal transplantation, whereas 
patients with a healthy iris showed minimal decrease in CECD (7). 
This suggests that the fate of CECD is, to an extent, already deter-
mined by the preoperative condition of the patient’s iris. Further-
more, congenital eye diseases harboring pathologic iris conditions, 
such as Axenfeld-Rieger (A-R) syndrome, or acquired pathologic 
iris conditions, such as iris cyst, iridoschisis, postsurgical iris atrophy, 
or iridocorneal endothelium (ICE) syndrome, have accelerated CEnC 
loss (8), often develop corneal endothelial dysfunction clinically 
(Fig. 1, A and B), and are known to have poor prognosis of trans-
planted grafts in patients who undergo corneal transplantation due 
to a rapid decrease in CEnCs (fig. S1, A and B). However, to date, 
the precise mechanisms underlying the rapid CECD decrease still 
remain elusive. Anatomically, the aqueous humor (AqH) presents 
between CEnC and the iris. We hypothesized that iris atrophy coincides 
with serious pathological alterations in the AqH, leading to CEnC 
loss in a specific biological pathway. We sought to test our hypothesis 
and identify the biological processes that drive CEnC loss in actual 
patients through the use of multiomic strategies from patient- 
derived samples. By doing so, we found abnormal activation of immune 
responses and disturbed energy homeostasis at the transcriptome 
and proteome levels. Furthermore, we confirmed the direct connection 
among CEnCs, iris, and AqH in a mouse strain that spontaneously 
develops iris atrophy, mimicking human pathologic iris atrophy. 
The multiomics landscape of AqH from patients with pathological 
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CECD decrease will not only help us develop therapeutic modalities 
for corneal transplantation patients with dysfunctional grafts but also 
decode the pathological networking among CEnCs, iris, and AqH.
RESULTS
Protein levels in AqH are associated with iris atrophy 
and poor corneal graft survival
Recent studies have a proposed potential pathophysiological associ-
ation among the iris, AqH, and CEnCs (7–11). Because of the minimal 
proliferative capacity of cells inside the eye, the wound healing process 
of the iris or CEnCs once damaged is limited. Thus, we hypothesized 
that iris atrophy can directly cause an irreversible disruption of the 
blood-aqueous barrier (BAB) and promote chronic pathological 
alterations in AqH, leading to rapid CEnC loss and irreversible corneal 
edema. We graded the severity of iris atrophy (fig. S1, C to G) as 
reported previously (7) and evaluated the prognosis of corneal 
transplantation stratifying the patients based on the iris atrophy 
severity. Consistent with our previous reports (7–12), in a prospective 
study excluding patients with immunological graft rejection that 
can cause bias, the corneal graft survival was poor in patient eyes with 
severe iris atrophy in two different surgical procedures, endothelial 
keratoplasty (EK; Fig. 1C and table S1, P < 0.0001) and penetrating 
keratoplasty (PK; fig. S2A, P = 0.0105).Next, we found that there 
was a significant correlation between the severity of iris atrophy and 
the protein concentration in AqH (Fig. 1D). For all experiments 
hereafter involving human subjects, ethical approval was provided 
by all local Institutional Review Board regarding tissue/AqH collection 
and use, as well as all patients provided informed consent. When 
these patients underwent corneal transplantation, the preoperative 
high level of protein in AqH was associated with rapid loss of CEnCs 
[post-EK, r = −0.408, P < 0.0001 at 12 months (Fig. 1E); post-PK, 
P < 0.03 at all time points (fig. S2B and table S2)] and shorter graft 
survival [post-EK, P < 0.0001 (Fig. 1F); post-PK, P = 0.0054 (fig. 
S2C)]. Cox proportional hazard models including various clinical 
factors identified preoperative high AqH protein levels as a significant 
risk factor for poor graft prognosis (table S3). Because of ethical reasons, 
we did not obtain postoperative protein levels in AqH. However, 
even after corneal transplantation, the high protein levels in AqH 
were expected to be maintained overtime since little recovery was 
expected once iris atrophy led to BAB disruption due to the poor 
healing capacity of the intraocular tissues.
Fig. 1. Condition of iris and AqH determines the prognosis of corneal transplantation. (A) CEnCs form a monolayer tissue in the posterior surface of the cornea and 
play a pivotal role in maintaining corneal transparency. Decreased CEnC number causes irreversible corneal edema, leading to loss of transparency. (B) Slit-lamp anterior 
segment microscopy imaging in A-R syndrome. Loss of transparency due to endothelial dysfunction–induced corneal edema. Pupil is distorted due to iris atrophy. In 
these eyes, aqueous humor (AqH) is inflamed. Photo credit: Takefumi Yamaguchi, Tokyo Dental College Ichikawa General Hospital. (C) Long-term graft survival stratified 
by iris atrophy severity after endothelial keratoplasty. The prognosis of eyes with severe iris atrophy score (IAS3 to IAS4) was significantly poor (n = 172; log-rank 
Mantel-Cox test, P < 0.0001). (D) Protein levels in AqH increase with iris atrophy severity in human eyes (Spearman’s correlation analysis, r = 0.468, P < 0.0001). (E) Correlation 
between preoperative protein levels in AqH and the CECD at 12 months after endothelial keratoplasty (Spearman’s correlation analysis, r = −0.408, P < 0.0001). Other time 
points are given in table S2. (F) Graft survival was significantly shortened in eyes with high preoperative AqH protein levels compared to those with lower protein levels 
(log-rank Mantel-Cox test, P < 0.0001). (G to J) Representative transmission electron microscopy (TEM) of healthy CEnCs (G and H) and CEnCs of bullous keratopathy (I and 
J). In bullous keratopathy (I and J), TEM reveals mitochondrial vacuolization, electron-dense deposits, and loss of cristae (red arrowheads). (K and L) JC-1 staining repre-
senting mitochondrial membrane potential in healthy CEnCs (K) and CEnCs of bullous keratopathy (L). Scale bars, 20 m. (All samples depicted are human). 
(M) Human CEnCs were cultured either in normal AqH cocktail (protein level, 0.466 mg/ml) or AqH cocktail from bullous keratopathy (2.40 mg/ml) for 48 or 24 hours, 
respectively. (N to Q) JC-1 staining. CEnCs were cultured in normal AqH for 48 hours (N), in normal AqH cocktail for 24 hours, and then transferred into AqH cocktail 
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Morphological alterations in human CEnC mitochondria
The long-term clinical data suggested that pathological micro-
environmental changes in AqH may trigger CEnC dysfunction. 
Therefore, we sought to elucidate cellular alterations in CEnCs when 
exposed to the AqH pathological microenvironment and assessed 
19 human CEnCs (13 from pathological corneas and 6 from healthy 
corneas obtained from SightLife Eye Bank, Seattle, WA, USA) using 
electron microscopy (table S4). A hexagonal CEnC monolayer 
covering Descemet’s membrane was observed in healthy human 
eyes by scanning electron microscopy (SEM; fig. S2D). In addition, 
examination of healthy corneal endothelium by transmission electron 
microscopy (TEM) revealed normal intracellular organelle, including 
healthy mitochondria with lamellae and cristae structures (Fig. 1, G to H). 
In contrast, SEM in eyes with bullous keratopathy revealed either a 
significantly reduced number of CEnCs with irregular dendritic 
structure (fig. S2E), and almost bared Descemet’s membrane with 
degenerated collagen fibers, or a completely CEnC-bared Descemet 
basement membrane with degenerated collagen fibers (fig. S2F). 
Moreover, flattened CEnCs (Fig. 1I) with evidence of damaged 
mitochondria such as extended vacuolization, electron-dense deposits, 
and a marked disruption of cristae (Fig. 1J, red arrowheads) were 
observed by TEM. Compared to healthy CEnCs (fig. S2G), bullous 
keratopathy CEnCs showed poor staining with MitoTracker Green, 
as well as mitochondrial vesicle formations (fig. S2H, red arrows). 
When examined with the mitochondrial membrane potential– 
dependent dye, JC-1, it was shown that mitochondria in healthy 
CEnCs maintained membrane potential (Fig. 1K), whereas a number 
of mitochondria in bullous keratopathy CEnCs lost their membrane 
potential (Fig. 1L), indicating dysfunctional mitochondria in bullous 
keratopathy CEnCs. To assess the effect of pathological AqH on 
CEnC mitochondria in vitro (Fig. 1M), 3 × 3 mm square-shaped 
pieces of human corneal endothelium were cultured in an AqH 
cocktail from normal eyes (protein level, 0.466 mg/ml) and in an 
AqH cocktail from eyes with bullous keratopathy (2.40 mg/ml). 
JC-1 staining of CEnCs showed normal mitochondrial membrane 
potential in those cultured in normal AqH cocktail for 48 hours 
(Fig. 1N) and those cultured in AqH cocktail from bullous keratopathy 
for 24 hours and then transferred into normal AqH cocktail for 
24 hours (Fig. 1O). However, mitochondrial membrane potential 
became depolarized in CEnCs cultured in AqH cocktails from 
bullous keratopathy for 24 and 48 hours (Fig. 1, P and Q), showing 
the direct effect of pathological AqH on mitochondrial membrane 
potential and also suggesting that the damage can be reversed by 
culture in normal AqH. It has been shown that CEnCs are vulnerable 
to mitochondrial stress due to their postmitotic nature and their 
highly exposed position to ultraviolet light radiation (13).
Proteomic analysis of human AqH
The long-term clinical outcome of corneal graft survival showed 
that the higher the AqH protein levels were, the more likely the corneal 
graft was to fail, suggesting that alterations at the protein levels may 
determine the fate of the graft. To identify proteins altered in the 
pathological AqH, we conducted a proteomic analysis using human 
AqH (five from bullous keratopathy with iris atrophy and five from 
healthy eyes) collected during corneal transplantation or cataract 
surgeries (table S4). After depletion of 14 abundant proteins using 
the MARS Hu-14 column, followed by tryptic digestion, a quantitative 
liquid chromatography–mass spectrometry analysis was performed 
(14), and 1162 proteins were identified in AqH. Compared to 
healthy controls, 265 proteins were found to be significantly changed 
(elevated, 150 proteins; reduced, 115 proteins) in eyes with bullous 
keratopathy with non–false discovery rate (non-FDR) and a P value 
less than 0.05 (Fig. 2, A and B). Notably, up-regulation of the com-
plement activation pathway (Fig. 2C) and down-regulation of the 
glycolytic process (Fig. 2D) were observed in the pathological 
AqH. Alterations in representative protein levels are given in the 
obtained heatmap (Fig. 2E). In eyes with bullous keratopathy, 
Semaphorin 3 and 7 and mitochondrial energy–producing proteins 
[ATP synthase subunit (ATP5s), nicotinamide adenine dinucleotide 
phosphate, and propionyl–coenzyme A carboxylase  chain] were 
significantly decreased, whereas complement factors, such as C1-9, 
and complement factor H were significantly increased. CD44 levels 
were also elevated in AqH of bullous keratopathy, which was previously 
shown to be up-regulated during CEnC culture with inappropriate 
quality for human CEnC injection therapy (15). The protein sets that 
were significantly elevated in bullous keratopathy AqH samples may 
regulate important biological pathways such as leukocyte-mediated 
immunity, immune response, response to stress, defense response, 
complement activation, and response to stimulus (Fig. 2F). In 
contrast, the protein sets that were significantly decreased in the 
same samples are associated with impairment of several metabolic 
processes such as monosaccharide biosynthetic process, nicotinamide 
nucleotide metabolic process, cell adhesion, NAD/NADH metabolic 
process, glycolytic process, and oxidoreduction coenzyme metabolic 
process (Fig. 2G). The Search Tool for the Retrieval of Interacting 
Genes/Proteins identified proteolysis (GO0030162, P = 1.78 × 10−39), 
immune response (GO0006955, P = 1.05 × 10−24), and complement 
activation (GO0030449, P = 3.96 × 10−24) as biological processes in 
up-regulated protein networks (Fig. 2H). On the other hand, NAD/
NADH metabolic process (GO0019674/0006757, P = 1.00 × 10−8), 
ATP biosynthetic process (GO0006754, P = 1.75 × 10−8), and glycolytic 
process (GO0006096, P = 4.89 × 10−8) were identified as biological 
processes in down-regulated protein networks (Fig. 2I). Hereditary 
Fuchs’ endothelial dystrophy, a major cause of CEnC dysfunction 
in Western countries and accounting for 4% of the population, has 
an unaffected AqH and a favorable prognosis for corneal transplan-
tation (16). Proteomic analysis in hereditary Fuchs’ endothelial 
corneal dystrophy samples (five eyes) revealed up-regulation of 
platelet degranulation and canonical glycolysis, which differed from 
both healthy controls (fig. S3, A to E) and bullous keratopathy sam-
ples (fig. S3, F to H).
Transcriptomic analysis of human CEnCs
Mitochondria are more than the energy powerhouse of the cell; they 
serve as mediators of hypoxic/reactive oxygen species signal trans-
duction, oxidative stress, cellular differentiation, and the cell cycle 
(17). As we have shown above, the TEM images and proteomic 
approach evidenced mitochondrial damage in CEnCs from bullous 
keratopathy. We next performed a transcriptomic analysis of CEnCs 
exposed to pathological AqH. We obtained primary CEnC tissue from 
15 patients undergoing corneal transplantation for the treatment of 
CEnC dysfunction (table S4). As healthy control, CEnC tissue from 
four corneas obtained from the Seattle Eye Bank were used. Follow-
ing tissue RNA extraction, we evaluated the quality of RNA for 
RNA sequencing (RNA-seq). Of 15 eyes with CEnC dysfunction, 
adequate RNA integrity number (RIN) above 6 was only achieved 
in seven eyes due to severe CEnC loss in the remaining eight eyes. 
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must be induced in CEnCs exposed to pathological AqH, we charac-
terized the transcriptional consequences in CEnC of seven individuals 
undergoing corneal transplantation. We identified 2385 up- 
regulated and 2880 down-regulated among 40,448 genes (Fig. 3, A and B), 
which were statistically significant with non-FDR P values less than 
0.05. Principal components (PC) analysis showed distinct relation-
ships between eyes with CEnC dysfunction and healthy eyes (PC1, 
42.0%; PC2, 11.7%; PC3, 9.2%), accounting for 62.9% of the variance 
observed between gene expression datasets (Fig. 3C). Two of six 
genes associated with hereditary corneal endothelial dystrophies 
[zinc finger E-box binding homeobox 1 (ZEB1) and solute carrier 
family 4 member 11 (SLC4A11)] were significantly down-regulated 
in bullous keratopathy CEnCs (down-regulated by 3.0- and 3.7-fold, 
P = 6.38 × 10−5 and 1.97 × 10−3, respectively) compared to healthy 
controls, while four [collagen type VIII 2 chain (COL8A2), 
transcription factor 4 (TCF4), lipoxygenase homology domains 1 
(LOXHD1), and ATP/guanosine triphosphate binding protein like 
1 (AGBL1)] were not. Whereas CEnCs have minimal expression of 
cytokine receptors to avoid responding against external stimuli in a 
steady state (18), the gene expression of cytokine receptors, such as 
interleukin (IL)–2r, IL-4r, and IL-17r, interferon-r (IFN-r) and 
apoptosis inducers, programmed cell death ligand (PD-L2), and 
cluster of differentiation 86 (CD86), were significantly up-regulated, 
suggesting that CEnCs may become susceptible to elevated cytokines 
in AqH of bullous keratopathy (10). Furthermore, in line with our 
electron microscopy findings, mitochondria-related genes, such as 
creatine kinase mitochondrial (CKMT), ATP synthase (ATPs), and 
solute carrier (SLCs) genes, were significantly down-regulated in eyes 
with bullous keratopathy compared to healthy controls (Fig. 3D). 
Gene transcripts that showed significantly different expression pro-
files between healthy eyes and eyes with bullous keratopathy were 
further analyzed for functional Gene Ontology (GO) enrichment, 
which identified several ongoing cellular components. Genes with 
significantly higher expression in eyes with bullous keratopathy 
demonstrated significant enrichment for several functional pathways 
such as extracellular matrix organization, cell adhesion, integrin- 
mediated pathway, signal transduction, IFN--mediated pathway, 
immune response and inflammatory response (Fig. 3E). On the 
other hand, genes with significantly lower expression in eyes with 
bullous keratopathy demonstrated significant enrichment for several 
down-regulated important processes such as canonical glycolysis, 
glyconeogenesis, PERK-mediated unfolded protein response, glycolytic 
process, cellular response to hypoxia, response to ischemia, mito-
chondrial electron transport, and oxidation-reduction process (Fig. 3F). 
Fig. 2. Proteomic analysis of AqH in bullous keratopathy. (A) Venn diagram displaying the number of statistically significant identified altered proteins in eyes with 
bullous keratopathy. (B) The results of FDR ≤ 0.05 (five healthy eyes versus five eyes with bullous keratopathy) depicted on a volcano plot. CFB, complement factor B; 
GAPD, glyceraldehyde-3-phosphate dehydrogenase; IDH, isocitrate dehydrogenase; LDH, lactate dehydrogenase; SOD, superoxide dismutase; TPI, triosephosphate 
isomerase; TKT, transketolase; TSP1, thrombospondin1; FC, fold change. (C and D) Complement factors were significantly elevated in bullous keratopathy as compared 
to healthy controls (C), whereas the glycolysis-related proteins were significantly decreased (D). IgG, immunoglobulin G; acetyl-coenzyme A, CoA. (E) Heat map illustrating 
quantitative alterations of representative proteins (BK, bullous keratopathy; CT, healthy controls). (F and G) Canonical biological processes which were significantly 
up-regulated (F) and down-regulated (G) in bullous keratopathy were characterized using DAVID GO analysis. (H and I) Functional association network of up-regulated 
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CEnC cellular senescence markers (19) were significantly altered in 
bullous keratopathy samples (P16INK4a, up-regulated by 91.6-fold, 
P = 2.43 × 10−6; p27Kip1, down-regulated by 4.22-fold, P = 1.07 × 10−7), 
as well as members of the senescence-related MGM2-E3 ubiquitin 
pathway (Fig. 3G). Furthermore, senescence-related genes, sirtuin 1 
(SIRT1) and nicotinamide phosphoribosyltransferase (NAMPT), 
which convert NAD+ to nicotinamide mononucleotide (NMN) (20), 
were also significantly reduced (4.12- and 3.06-fold, P = 1.28 × 10−6 
and 7.5 × 10−5, respectively), whereas solute carrier family 12 member 
8 (SLC12A8), which was recently identified as a NMN transporter 
(21), was significantly up-regulated in bullous keratopathy CEnCs 
(2.83-fold, P = 2.21 × 10−3).
To validate the influence of the up-regulation of cytokine receptors, 
we compared AqH cytokine levels between 194 eyes with bullous 
keratopathy and 51 healthy eyes using flow cytometric immunobeads 
assay (table S5) and confirmed significant elevations in cytokine 
levels for IL-4, IL-10, IL-17a, IFN-, and soluble intercellular adhesion 
molecule 1 (sICAM-1) in bullous keratopathy samples (Fig. 3H). A 
recent report has demonstrated that elevated levels of IL-10 represent 
“chronic pathological inflammation” due to negative feedback 
mechanism (22). Similarly, RNA-seq results also indicated higher 
oxidative stress response in eyes with bullous keratopathy. To test 
for oxidative stress, we measured the levels of 8-hydroxy-deoxy- 
guanosine (8-OHdG), a critical biomarker for oxidative stress, in 
AqH using enzyme-linked immunosorbent assay and confirmed 
significant elevation of 8-OHdG levels in AqH of bullous keratopathy 
(33 eyes, 0.23 ± 0.12 pg/ml) compared to healthy controls (27 eyes, 
0.15 ± 0.06 pg/ml, P = 0.0051; Fig. 3I and table S5). Immuno-
histological evaluation also showed 8-OHdG–positive CEnCs in 
bullous keratopathy (Fig. 3J).
Development of iris atrophy in DBA2J coincides with  
CEnCs loss
Through the prospective proteomic and transcriptomic analyses of 
patient-derived samples, we could accumulate plenty of evidence 
indicating the tight link among CEnCs, iris, and AqH. To further 
investigate the cause and effect of these integrative networks, we 
adopted a murine model to be used by mimicking iris atrophy. The 
DBA2J mouse strain, which spontaneously develops pigmentary 
dispersion and iris atrophy (Fig. 4A), is widely used as a murine 
glaucoma model (23). However, little is known on the CEnC state in 
DBA2J. Immunohistochemical analysis of zonula occludens-1 (ZO-1) 
in CEnC revealed significant cell loss in DBA2J mice at 20 weeks as 
compared to those at 6 weeks (P < 0.0001), whereas there were no 
Fig. 3. Transcriptomic analysis of CEnCs in bullous keratopathy. (A) Venn diagram displaying the number of statistically significant identified altered genes in CEnCs 
with bullous keratopathy. (B) The principal components analysis results clearly divided healthy and dysfunctional CEnCs (seven eyes with bullous keratopathy versus four 
healthy eyes). (C) The results of FDR < 0.05 (healthy eyes versus bullous keratopathy) depicted on a volcano plot. (D) Heatmap illustrating quantitative alterations of 
representative genes. (E and F) Canonical biological process were significantly up-regulated (E) and down-regulated (F) in CEnCs of bullous keratopathy were characterized 
using DAVID GO analysis. (G) Significant alterations in the Wnt/MGM2/PGAM2 and SIRT1/NAMPT/SLC12A8 pathways, such as up- and down-regulation of the CEnC 
senescence markers, p27Kip1 and p16INK4a, implicated stress-induced senescence in bullous keratopathy. (H and I) Inflammatory cytokine (H) and 8-OHdG (I) levels were 
significantly up-regulated in eyes with bullous keratopathy (cytokine, n = 194 eyes; 8-OHdG, n = 33 eyes) as compared to healthy controls (cytokine, n = 51 eyes; 8-OHdG, 
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significant differences in CECD between 6- and 20-week BALBc 
control mice (Fig. 4B). Electron microscopy of CEnCs on DBA2J mice 
at 20 weeks showed mitochondrial vacuolization (Fig. 4C, red arrow-
heads), which was observed in human samples (Fig. 1J). In addition, 
MitoTracker staining showed significant loss of mitochondrial mass 
in 20-week compared to 6-week-old DBA2J mice (Fig. 4C). JC-1 
staining revealed loss of mitochondrial membrane potential in 
20-week DBA2J compared to 20-week BALBc control mice (Fig. 4D).
We hypothesized that iris atrophy in DBA2J mice could stand as 
a candidate murine model of CEnC damage induced by iris atrophy 
and the pathological AqH microenvironment. We measured the 
protein level in AqH, which showed significant elevation from 0.94 
to 4.02 mg/ml at 20 weeks in DBA2J mice (P < 0.0001), whereas it 
stayed around 0.95 mg/ml in BALBc control mice (Fig. 4E). Previous 
reports showed that the leukemia inhibitory factor (LIF) reduces 
tight junction and cell survival via signal transducer and activator of 
transcription 3 (STAT3) signaling in CEnCs (24), and high levels of 
IL-6 and monocyte chemotactic protein-1 (MCP-1) in AqH were 
associated with rapid CEnC loss after corneal transplantation in human 
(10, 11). Thus, we assessed protein levels of 14 cytokines in the AqH 
of DBA2J and BALBc mice using a multiplex bead array assay. The 
levels of inflammatory cytokines, IL-6, MCP-1, and LIF, in the AqH, 
were significantly elevated at 20-week DBA2J mice, compared to 
those of 6-week DBA2J and 6- and 20-week BALBc mice (Fig. 4F). 
Where did these AqH alterations in protein levels derive from? 
AqH faces the cornea and the iris. Therefore, we measured protein 
levels of these cytokines in cornea and iris tissues. IL-6, MCP-1, and 
LIF protein tissue levels were significantly elevated in the iris at 
20-week DBA2J mice, compared to those of 6-week DBA2J and 6- 
and 20-week BALBc mice (Fig. 4F). Concurrently, these cytokine 
levels were significantly elevated in the cornea of DBA2J mice both 
at 6- and 20-weeks, compared to those in BALBc mice, demonstrating 
a similar elevation pattern of cytokines in the iris and the AqH. These 
increases of inflammatory cytokines can recruit immune cells into 
the AqH. Therefore, we collected AqH cellular aggregates after 
centrifuging of AqH from 20-week-old DBA2J mice, which contained 
significant number of immune cells (Fig. 4G), compared to 6-week-old 
DBA2J mice (P < 0.0001). In contrast, there were no immune cells 
in AqH from those of BALBc mice. We also tested the cellular 
components in human AqH. The cell pellet smear from bullous 
Fig. 4. The DBA2J murine model mimics the human bullous keratopathy pathology. (A) Iris structure is normal in DBA2J mice at 6 weeks (red arrowheads); however, 
iris stromal atrophy spontaneously develops at 20 weeks (red arrows). Scale bars, 100 m. Photo credit: Kazunari Higa, Tokyo Dental College Ichikawa General Hospital. 
(B) Immunohistochemistry of ZO-1 in DBA2J mice. CECD significantly decreased at 20 weeks in DBA2J mice, whereas no significant difference was noted in BALBc mice 
(all, n = 5 mice). Scale bars, 50 m. (C) Electron microscopy revealed mitochondrial vacuolization at 20 weeks (right, red arrowheads) similar to what was observed in 
human CEnCs of bullous keratopathy, whereas mitochondria appeared normal at 6 weeks (left). Scale bars, 500 nm. CEnC mitochondrial mass (by MitoTracker) was 
significantly decreased at 20-week compared to 6-week mice. Scale bars, 20 m. (D) JC-1 staining was decreased in 20-week DBA2J compared to 20-week BALBc mice. 
Scale bars, 20 m. (E) Protein levels were significantly elevated from 6- to 20-week DBA2J mice (all, n = 6 mice, P < 0.0001), whereas no statistical difference was observed 
in BALBc mice. (F) AqH IL6, monocyte chemotactic protein-1 (MCP-1), and LIF protein levels were significantly elevated at 20-week compared to 6-week DBA2J mice. Iris 
IL-6, MCP-1, and LIF protein levels were significantly elevated at 20-week compared to 6-week DBA2J mice (all, n = 12 mice, P < 0.0001), whereas corneal IL-6, MCP-1, and 
LIF protein levels were elevated at both 6- and 20-week DBA2J, as compared to BALBc mice. ND, not detected. (G) A significant increase in the number of immune cells 
in the AqH was observed in 20-week compared to 6-week and BALBc mice. Scale bars, 50 m. Unpaired Student’s t test, *P < 0.01. (H) Immune cells were positive for 
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keratopathy samples showed significantly increased number of 
immune cells in AqH, whereas no cells were detected in AqH of 
healthy controls (fig. S4, A to C; P = 0.0005). The immune cells in 
the AqH were positive for CD10 and myeloperoxidase (MPO) both 
in DBA2J (Fig. 4G) and human patients (fig. S4D), indicating that 
they are neutrophils. The clinical relevance of cytokines in AqH has 
been already emphasized regarding the prognosis of corneal trans-
plantation (9–12). However, to date, the source of cytokines in AqH 
remains elusive. These results collectively suggest that the atrophic 
iris tissue contains similar cytokine components, inducing immune 
cell recruitment into AqH. Since DBA2J is a murine model for 
pigmentary dispersion glaucoma, to exclude the possibility that 
glaucoma development might affect our results, we therefore 
measured intraocular pressure (IOP), which was shown to remain 
at normal levels until 20 weeks (fig. S5A). All these phenotypes 
observed in DBA2J mice resembled those of bullous keratopathy in 
humans, suggesting that elevated inflammatory protein levels in 
AqH coincided with iris atrophy and immune cell recruitment, 
which might cause CEnC damage in DBA2J mice.
Transplantation of DBA2J CEnC layer into BALBc  
anterior chamber
Despite all indications to the contrary, CEnC loss could be attributable 
to an unidentified DBA2J phenotype independent of AqH and not 
associated with microenvironmental alterations in AqH. To demon-
strate the direct association between CEnC damage and the patho-
logical AqH microenvironment in DBA2J mice, we next transplanted 
the cornea of 20-week DBA2J mice into the anterior chamber of 
young BALBc/DBA2J mice and vice versa (Fig. 5A). After removing 
the corneal epithelium, wedge-shaped corneal grafts (approximately 
0.3 mm × 1.5 mm) were transplanted into the anterior chamber of 
the recipients and lifted with air injection beneath the grafts (25). 
All syngeneic (from young to old and from old to young DBA2J 
mice) and allogeneic transplants from BALBc to DBA2J mice failed 
within 1 to 7 days. In contrast, allogeneic transplants from DBA2J 
to BALBc mice successfully survived (Fig. 5B, P < 0.0001). We 
confirmed that the graft failure was caused by the decreased density 
of CEnCs in the graft (Fig. 5, C and D). CECD of the 20-week 
DBA2J corneal grafts was significantly decreased after transplantation 
Fig. 5. Convalescence of DBA2J CEnCs when transplanted into BALBc mice. (A) Corneal endothelial tissues were transplanted from 6- and 20-week DBA2J into 
6-, 20-week DBA2J, or BALBc mice to evaluate whether CEnC damage in DBA2J mice is due to the pathological AqH microenvironment secondary to the atrophic iris. 
Unexpectedly, 6-week DBA2J mice developed severe inflammation after syn-/allogeneic grafts, and all ended in graft failure. (B) Representative images of corneal grafts. 
Failed grafts became white and edematous. DBA2J (syngeneic) and BALBc (allogeneic) grafts into DBA2J mice failed within a week despite the absence of apparent 
immunological rejection, whereas grafts into BALBc mice successfully survived (n = 10 to 12 mice, log-rank Mantel-Cox test, P < 0.0001). Photo credit: Kazunari Higa, Tokyo 
Dental College Ichikawa General Hospital. (C and D) To confirm whether graft failure was due to corneal endothelial decompensation, we assessed graft CEnCs by mito-
chondrial staining (MitoTracker). Failed grafts exhibiting mitochondrial vacuolization (red arrowheads) and decreased number of CEnCs. Notably, CEnCs transplanted 
from 20-week DBA2J to BALBc mice were normal (yellow arrowheads). Scale bars, 50 m. NS, not significant. (E) Cytokine levels in AqH after corneal transplantation were 
measured using a multiplex immunobead assay. Cytokine levels were significantly elevated in eyes with failed grafts (DBA2J/BALBc to DBA2J), whereas in eyes with 
survived grafts (DBA2J to BALBc). Unpaired Student’s t test, *P < 0.01. (F) Immune cells numbers in AqH after corneal transplantation remained at the same levels in 
20-week DBA2J mice compared to those in a steady state, whereas they were significantly increased in eyes with allogeneic transplantation (BALBc to DBA2J), in which 
cytokine levels were extraordinarily elevated. Scale bars, 50 m. (G) JC-1 staining revealed that mitochondrial membrane potential was reversed in grafts transplanted 
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into the anterior chamber of 6-week DBA2J mice and vice versa 
(P < 0.0001), whereas it remained stable when transplanted into the 
anterior chamber of BALBc mice. We expected that the corneal 
grafts would survive into young DBA2J mice as these had normal 
protein levels in the steady state (Fig. 4E). However, they all clinically 
developed iris pigment dispersion and failed. Therefore, to determine 
the alterations in AqH microenvironment, we measured cytokine 
levels after corneal transplantation. We found that the IL-6, MCP-1, 
and LIF levels in AqH significantly increased after corneal trans-
plantation in 6-week DBA2J mice (Fig. 5E, P < 0.0001), indicating 
that the DBA2J is hypersensitive to minimally invasive operation 
and alters AqH environment inflammatory (26). In 20-week DBA2J 
mice after syngeneic transplantation, IL-6 and LIF levels were 
moderately elevated compared to those in a steady state; however, 
the number of immune cells did not increase (Fig. 5F), suggesting 
that CEnCs decreased due to humoral factors in AqH rather than 
cellular reactions. In the allogeneic transplantation from BALBc to 
DBA2J mice, IL-6 level in AqH was significantly increased up to 
1283 ± 29 pg/ml as well as the number of immune cells in AqH 
(Fig. 5F). CEnCs of the graft transplanted from 20-week DBA2J to 
BALBc mice showed increased mitochondrial potential, compared 
to that of 20-week DBA2J (Fig. 5G), which suggests that pathological 
CEnC mitochondrial alterations in old DBA2J mice can be reversed, 
and CEnCs can turn to normal when transplanted into a healthy 
microenvironment.
DISCUSSION
The current study identified several biological processes that were 
up- and down-regulated in the human AqH and CEnCs. Further, 
electron microscopy revealed that CEnCs in bullous keratopathy 
exhibited serious mitochondrial stress with severe loss of cristae 
and abnormal vacuolization. Recently, we showed that preoperative 
cytokine levels in AqH were correlated with CECD after corneal 
transplantation (8–11), suggesting that the pathological micro-
environment in AqH induces CEnC apoptosis. However, the exact 
mechanism remains elusive. The multiomics approaches from human 
samples suggested the following mechanisms: First, iris atrophy 
results in BAB disruption and elevated protein levels, with concurrent 
complement activation and oxidative stress in the AqH. Second, 
because of chronic exposure to such altered AqH environment, the 
cytokine receptors are up-regulated in CEnCs despite their minimal 
expression in steady state. Simultaneously, the abnormal AqH induces 
down-regulation of glycolysis, intracellular respiration, and NAD/
NADH metabolism in the CEnCs, leading to mitochondrial degen-
eration, and lastly, to CEnC loss (Fig. 6).
Previous histopathological studies have reported degeneration, 
decrease, or absence of CEnCs in patients with bullous keratopathy 
(27). However, little was known about organelle changes and their 
relation to cellular biological processes under pathologic conditions. 
Consequently, our current observations raise the question: Is the 
exhibited mitochondrial ultrastructure in our study (loss of cristae 
and vacuolization) specific to bullous keratopathy cases? On the basis 
of literature review of various types of diseases, it is made apparent 
that mitochondrial ultrastructure varies widely among pathologies. 
Regarding mitochondrial diseases, in Leber’s hereditary optic neuro-
pathy, the mitochondria occupying the cytoplasm were filled with 
stacked cristae (“mitochondria stream”), whereas, in chronic pro-
gressive external ophthalmoplegia, mitochondria were swollen and 
had lost inner cristae exhibiting an “onion-ring appearance” (28). 
On the other hand, TEM revealed abnormal endoplasmic reticulum 
and severely swollen mitochondria in Fuchs’ endothelial corneal 
dystrophy (29).
Recent studies have revealed that mitochondria are not only the 
energy powerhouse of the cell but also serve as mediators of cell 
signaling, regulation of metabolism, cell cycle control, development, 
antiviral responses, and cell death (17). In line with the abnormal 
mitochondrial ultrastructure, CEnC transcriptomic results showed 
Fig. 6. Comprehensive mechanism of bullous keratopathy development. (A) Healthy iris pigmentary epithelial cells in a steady state exhibit immunomodulatory 
property. Protein and cytokines levels in AqH are normal, and no immune cells are present. Thus, CEnCs are kept healthy. (B) In bullous keratopathy eyes with atrophic 
iris, iris tissue produces high levels of cytokines, such as IL-6, MCP-1, and LIF, which are released into AqH, and, in turn, recruit immune cells into AqH. Atrophic iris also 
results in the breakdown of the BAB. Subsequently, proteins, cytokines, and complement factor levels in AqH increase. Chronic exposure to this AqH environment leads 
to up-regulation of cytokine receptors expression in the surface of CEnCs. Such pathological microenvironment alterations lead to mitochondrial vacuolization, increased 
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alterations in various genes reported to lead to mitochondrial dys-
function. Both ZEB1 and SLC4A11, genes that are responsible for 
hereditary corneal endothelial dystrophies, were significantly reduced 
in CEnCs of bullous keratopathy compared to controls. ATP5 genes, 
which are subunits of ATP synthetase and regulate SIRT3 to restore 
mitochondrial function in response to stress, were also significantly 
reduced (30). CKMT1 is another important gene for global cell 
metabolism, including purine metabolism, amino acid metabolism, 
and energy metabolism (tricarboxylic acid cycle and glycolysis), 
and its suppression renders mitochondria dependent on creatine 
pathway activity for ATP production (31). The coiled-coil-helix 
coiled-coil helix domain containing 10 (CHCHD10), which is an 
amyotrophic lateral sclerosis causative gene and can single handedly 
promote loss of cristae junction with impaired mitochondrial genome 
maintenance after oxidative stress (32), was significantly down- 
regulated (3.70-fold, P = 3.53 × 10−5). Further, the solute carrier 
family 25 member 25 (SLC25A25), gene absence of which leads to 
energy insufficiency in the cell and leads to reduced physical endurance 
(33), was significantly down-regulated in CEnCs of bullous kera-
topathy (6.19-fold, P = 1.64 × 10−7). SLC25A25 is a Ca2+-sensitive 
ATP-Mg2+/Pi carrier in the inner mitochondria membrane, which 
plays an important role in the regulation of ATP homeostasis 
necessary to support Ca2+ cycling (33). Research on the biology of 
NAD+ cofactor has provided many critical insights into the patho-
genesis of age-associated diseases (20). Supplementing NAD+ inter-
mediates, such as NMN, yields preventive and therapeutic effects, 
ameliorating age-associated pathophysiologies and diseases, such as 
diabetes mellitus, retinal/neuronal ischemia, dementia, and heart 
diseases by improving mitochondrial function (20).
It has been reported that allogeneic skin grafts from DBA2 to 
BALBc were all rejected within 14 days (34). The results of graft 
survival from DBA2 to BALBc in the current study suggested an 
ocular specific mechanism, such as anterior chamber–associated im-
mune deviation (ACAID) (25). The endothelial lamellar keratoplasty 
procedure used in the current study is reported to induce ACAID 
(26). Moreover, this minimally invasive procedure without any corneal 
sutures causes almost no surgery-induced inflammation (Fig. 5B). 
In contrast, conventional full thickness keratoplasty is relatively 
invasive, needing removal of corneal sutures at 7 days to prevent 
inflammation and neovascularization. Furthermore, after full thickness 
keratoplasty from DBA2J to BALBc, the graft survival rate is reported 
to be 0% due to immunological rejection (35), which can cause sig-
nificant reduction in CECD (36). Thus, we selected endothelial 
lamellar keratoplasty in the current study.
Regarding its ocular phenotype of DBA2J, Chang et al. (23) first 
reported severe iris atrophy and pigment dispersion glaucoma. 
They also mentioned that iris abnormality in DBA2J resembles ICE 
syndrome, essential iris atrophy, and A-R syndrome in human, which 
develop corneal endothelial decompensation and have an extremely 
poor graft prognosis after cornel transplantation. The DBA2J 
phenotype is reported to be caused by mutations in the glycoprotein 
Nmb (Gpnmb) and tyrosinase-related protein 1 (Tyrp1) genes. 
Tyrp1 encodes a component of a melanosomal membrane protein 
complex involved in pigment production, whereas Gpnmb is less 
characterized but also presents in melanosomes (23). The corneal 
transplant results in this study (DBA2J to BALBc) demonstrated a 
reversible CEnC change, suggesting direct damage of CEnCs by the 
pathological AqH environment in DBA2J mice. Thus, we propose 
that CEnC damage is associated with the pathological iris alterations 
and subsequent microenvironmental changes in the AqH and sug-
gest that CEnC damage can be reversed by adjusting the AqH 
microenvironment appropriately.
Innate immunity plays a major role in resistant to tolerance 
induction and further amplifies graft-specific adaptive immunity, 
although innate immune mechanisms are not sufficient to lead to graft 
rejection (37). In solid organ transplantation, ischemia/reperfusion 
injuries initiate innate immunity, which, in turn, enhances immuno-
genicity through the activation of antigen-presenting cells (37). In 
contrast, in the cornea, deprivation of immune privilege has been 
well-investigated through the activation of adaptive immunity, such 
as induction of neovascularization. However, innate immunity in 
the cornea is still elusive. In the current study, severe inflammation 
leading to syngeneic graft dysfunction in DBA2J mice is not antigen- 
specific adaptive immunity but can be a neutrophil-mediated innate 
immune response. This response was exacerbated in allogeneic 
BALBc grafts into DBA2J AqH. Preactivated innate immunity in 
the AqH with iris atrophy (elevated protein levels, the presence of 
neutrophil, complement activation, etc.) suggested from human 
experiments is still needed for further studies, especially in relation 
to immune privilege and humoral factors leading to loss of CEnCs 
and corneal graft failure. Together with clinical studies, we believe 
that DBA2J can serve as a suitable model for the future studies to 
specify therapeutic molecules.
This study had some limitations, the lack of a therapeutic angle, 
for instance. However, the use of DBA2J murine model in ocular 
studies provides several benefits. At first, a murine model will help 
us clarify the spatiotemporal biological processes, since differentiating 
primary pathological causes and secondary responses has been dif-
ficult in humans due to ethical reasons. Second, immune responses 
and wound healing capacity are kept to a minimum without being 
influenced by systemic conditions, given its immune privileged status; 
thus, this model can be a good candidate to investigate the relation-
ship between microenvironmental alterations and cellular response 
in vivo. Third, we have direct access to the cornea with minimal 
surgical manipulation, which will enable us to conduct clinical 
evaluations and intravital imaging for cellular responses to develop 
therapeutic interventions in the future.
We propose a mechanism whereby the inflamed state of AqH 
leads to up-regulation of cytokine receptors and Wnt signaling in 
CEnCs, resulting in the stress-induced senescence of CEnCs (Fig. 3G). 
CEnCs have unique properties. For example, human CEnC longevity 
exceeds 100 years without cell division. In addition, human CEnC 
numbers decrease gradually; their loss takes years in chronic senes-
cence process. There is increasing evidence suggesting that cellular 
senescence is accelerated through complement-mediated Wnt sig-
naling (38) and down-regulation of Sirtuins/NAD+ metabolic path-
way (21, 22, 31). Bullous keratopathy and graft failure due to CEnC 
loss are sight-threatening complications arising in some of the most 
common forms of blindness treatment procedures, such as cataract, 
glaucoma, and retinal surgeries. These results we have shown here 
warrant clinicians to avoid iris damage during surgeries, to prevent 
development of bullous keratopathy with poor prognosis for corneal 
transplantation. The current study also showed that the pathological 
microenvironment alteration resulting from iris atrophy following 
these intraocular surgeries can accelerate the stress-induced senes-
cence of CEnCs and CEnC loss. Future spatiotemporal studies will 
further elucidate the association between stress-induced senescence 
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behind these pathologies may allow clinicians/eye banks to optimize 
the corneal donor tissues for patients undergoing corneal transplantation. 
That is, donor CEnCs from 90-year-old individuals can survive for 
several decades in young recipients’ eyes under healthy conditions 
(such as keratoconus), whereas, in challenging eyes with severe iris 
atrophy, such as in A-R syndrome and ICE syndrome, CEnCs from 
20-year-old donors may survive longer than those from 90-year-old 
donors. Corneal tissue is one of the limited medical resources, 
especially in Asian countries, as the number of donors is still small 
compared to that of waiting patients. Selecting corneas from younger 
donors to be transplanted to individuals with complicated bullous 
keratopathy and severe iris atrophy may prolong graft survival 
rates. Moreover, the average age of donors is increasing in Japan, 
which is a potentially serious problem for long-term prognosis of 
corneal transplantations. Social action to inform the public and 
share this knowledge will contribute to increased donor numbers 
from the younger generation, which we believe will improve overall 
prognosis in worldwide corneal transplantations.
MATERIALS AND METHODS
Study design
The end goal of this study was to identify the role of the iris atrophy– 
induced pathological AqH microenvironment in CEnC dysfunction 
and loss and further demonstrate DBA2J as a murine model of 
CEnC loss, which will help evaluate the underlying spatiotemporal 
pathological mechanism in the future. The clinical procedures, out-
comes, and associated laboratory methods for cytokine measurement 
have been reported in detail previously (8–12). By analyzing protein 
and cytokine levels in the AqH from patients with bullous keratopathy 
versus a control cohort (uncomplicated cataract), we evaluated their 
influence on the long-term prognosis of corneal transplantation. 
Stored AqH samples and clinical data were analyzed after 3-year 
clinical observations were completed. We subsequently used the DBA2J 
mouse strain, which spontaneously develops iris atrophy as a model 
of CEnC loss. In patients with bullous keratopathy undergoing corneal 
transplantation, CEnC loss, a critical factor for long-term prognosis, 
can be influenced by donor factors (age, sex, the presence of diabetes, 
history of intraocular surgeries, etc.), surgical factors (surgeons’ ex-
perience, surgical time, simultaneous procedures, etc.), and recipient 
factors (age, bullous keratopathy etiologies, iris atrophy, diabetes, 
and history of glaucoma). Thus, we evaluated the various parameters 
(CECD and protein/cytokine levels), estimated SE and P values 
from the Student’s t test and Spearman’s correlation coefficients, 
based on previous reports, and determined sample size.
Clinical study
A prospective clinical study on long-term prognosis of corneal 
transplantation related to iris atrophy and AqH was conducted in 
Tokyo Dental College Ichikawa General Hospital from October 
2015 to June 2019 in accordance with the Declaration of Helsinki. 
The study was approved by the Institutional Ethics Review Board of 
Tokyo Dental College (I15-42R, I15-44, and I17-78). Written informed 
consent was obtained from all participants before the interventions. 
Iris atrophy severity was defined as iris depigmentation, laser iridotomy, 
or iris defect due to intraocular surgeries (7). The severity grade of 
iris atrophy for each case was determined on the basis of its severity 
from slit- lamp findings in a blinded manner by one of two corneal 
specialists (T.Y. or Y.Y.-Y.). Briefly, normal eyes are regarded as “no 
iris atrophy” (fig. S1C), eyes with “mild iris atrophy” are defined as 
iris atrophy limited to only one (fig. S1D) to two quadrants (fig. S1E), 
and eyes with “severe iris atrophy” are defined as iris atrophy from 
three (fig. S1F) to four quadrants (fig. S1G).
Patient demographics
The etiologies of patients undergoing EK included pseudophakic/
aphakic bullous keratopathy (PBK/ABK, 152 eyes), Fuchs’ endothelial 
corneal dystrophy (20 eyes), and those undergoing PK included PBK/
ABK (63 eyes), corneal scar (27 eyes), keratoconus (10 eyes), and 
hereditary corneal dystrophies (2 eyes). Comorbidity of glaucoma 
was significantly high in eyes with iris atrophy. In patients under-
going EK, glaucoma was present in seven patients without iris atro-
phy (13.0%), in 17 patients with mild iris atrophy (IDA1-2, 25.4%), 
and in 21 patients with severe iris atrophy (IDA3-4, 52.3%; 2 test, P < 
0.0001). In patients undergoing PK, glaucoma was present in 4 pa-
tients without iris atrophy (9.5%), in 8 patients with mild iris atrophy 
(30.8%), and in 12 patients with severe iris atrophy (35.3%; P = 
0.188). The number of previous intraocular surgery was 1.6 ± 1.4 
(0 to 9) in eyes undergoing EK and 1.9 ± 1.6 (from 0 to 9) in eyes under-
going PK. The protein levels in AqH was significantly correlated with 
the number of previous intraocular surgery [r = 0.419 (in EK) and 
0.575, both P < 0.0001]. Topical steroids were prescribed in 47 patients 
(27.3%) before EK and 30 patients before PK (29.4%).
Corneal transplantation procedures and  
postoperative management
We performed corneal transplantation, conventional PK, and modern 
lamellar keratoplasty, Descemet stripping automated endothelial 
keratoplasty (DSAEK), in a standard fashion as previously described 
(9–12). Both after PK and DSAEK, all patients were prescribed the 
eye drops levofloxacin (Santen, Osaka, Japan) and betamethasone 
0.1% eye drops (Santen) for use five times a day. Topical betamethasone 
eye drops were tapered over the following 6 months. At 6 months 
post-PK and DSAEK, we prescribed 0.1% fluorometholone eye drops 
(Santen) three times a day for up to 12 months after surgery, then 
tapered to two times a day, and continued to prevent graft rejection 
overtime. Some patients had mild IOP elevation more than 21 mmHg 
(43 patients after EK and 41 patients after PK), which resolved with 
topical antiglaucoma agents and management with topical steroids. 
Three patients underwent glaucoma surgery due to refractory IOP 
elevation after PK and were excluded from the study. Twelve patients 
who developed graft rejection (nine patients after PK and three 
patients after DSAEK) during follow-up and were also excluded 
from the study. We excluded from the correlation analyses eight eyes 
in which air injection was performed for the treatment of postoperative 
double chamber, due to air injection being associated with CECD loss 
after corneal transplantation.
Electron microscopy
Samples for electron microscopy observation were prepared as pre-
viously described (39). Briefly, human corneas were primary fixed 
with 2.5% glutaraldehyde for 12 hours at 4°C. Pinned corneas on 
silicone sheet were washed with 0.1 M phosphate buffer (pH 7.4) 
(Muto Pure Chemicals, Tokyo, Japan) and postfixed with 1% osmi-
um tetroxide (OsO4, TAAB Laboratories Equipment Ltd., England, 
UK) at 4°C, dehydrated in a series of increasing concentrations of 
ethanol and in 100% ethanol in the final dehydration step. Human 
corneal samples were dissected into several pieces for TEM and also 
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soaked in acetone (Sigma-Aldrich, MO, USA), with n-butyl glycidyl 
ether (QY1, Okenshoji Co. Ltd., Tokyo, Japan), then in graded 
concentration of Epon with QY-1, and embedded into 100% Epon 
[100 g of Epon is composed of 27.0 g N-methyl-4-nitroaniine, 51.3 g 
of EPOK-812, 21.9 g of dodecenyl succinic anhydride, and 1.1 ml of 
2,4,6-tris(dimethylaminomethyl)phenol all from Okenshoji Co. Ltd., 
Tokyo, Japan] for 12 hours. Infiltration of pure Epon was enhanced 
for 48 hours at 4°C. Polymerization with pure Epon was completed 
for 72 hours at 60°C. The ultrathin sections with 70-nm thickness 
were prepared on the copper grids with an ultramicrotome (Leica UC7, 
Leica Biosystems, Wetzlar, Germany) and stained with uranyl acetate 
and lead citrate for 10 min each. Sections were observed under an elec-
tron microscope using TEM (JEM-1400plus, JEOL, Tokyo, Japan). 
For SEM analysis, cornea samples were freeze-dried with 100% 
t-butyric alcohol (VFD-21S, Vacuum device, Ibaraki, Japan). The 
specimens attached to the aluminum stage with double- sided car-
bon tape and carbon paste were coated with platinum and palladi-
um using conductive heavy metal coater at a current of 6 mA for 90 
s (SC-701, Sanyu Electron Co. Ltd., Tokyo, Japan) and observed using 
SEM (SU6600, Hitachi High-Tech, Tokyo, Japan).
CEnCs culture in normal and pathological AqH cocktails
For in vitro experiment, AqH cocktails were prepared from AqH 
collected at the beginning of 15 normal cataract surgeries (normal 
AqH cocktail; protein level, 0.466 mg/ml) and AqH collected at the 
beginning of 23 corneal transplantations for the treatment of bullous 
keratopathy (bullous keratopathy AqH cocktail; protein level, 
2.40 mg/ml). Human corneal endothelial tissues imported from 
CorneaGen (Seattle, WA, USA) were carefully cut into 3 mm × 3 mm 
pieces using disposable blades. Corneal endothelial tissues were cul-
tured in 150 l of normal and bullous keratopathy-AqH cocktails at 
37°C for 48 hours and stained using JC-1 (#924, MitoPT JC-1, 
ImmunoChemistry Technologies, Bloomington, MN, USA). To assess 
whether mitochondrial membrane potential is reversible, AqH cocktails 
were exchanged from normal to bullous keratopathy and vice versa 
at 24 hours during culture and stained using JC-1 at 48 hours.
Proteomic analysis
A total of 15 AqH samples were collected during corneal transplan-
tations or cataract surgeries (five eyes with bullous keratopathy, five 
eyes with Fuchs endothelial corneal dystrophy, and five cataract eyes 
without comorbidity; table S4). The AqH samples were centrifuged 
at 3000g for 3 min, and the soluble fractions were collected and stored 
at −80°C until measurement. After depleting abundant proteins using 
MARS Hu-14 column (Agilent, Santa Clara, CA, USA), proteins were 
reduced, alkylated, and lastly digested with 5 l of immobilized trypsin 
(Thermo Fisher Scientific, Waltham, MA, USA) with shaking at 1000 rpm 
at 37°C for 6 hours. After removal of sodium deoxycholate and sodium 
N-lauroylsarcosinate, the resulting peptides were desalted and subjected 
to mass spectrometric analysis. Peptides were analyzed by Orbitrap 
Fusion Lumos mass spectrometer (Thermo Fisher Scientific). Protein 
identification and label-free quantification analysis were performed 
with Proteome Discoverer 2.2 software (Thermo Fisher Scientific). 
The tandem mass spectrometry spectra were searched against the 
Homo sapiens protein database in SwissProt (www.nextprot.org/), with 
an FDR set to 1% as an identification filter. For the AqH protein 
analysis, all detected peaks were standardized by adjusting the median 
value to 1.0 × 104. GO analysis was conducted using DAVID (https://
david.ncifcrf.gov/tools.jsp) and STRING (https://string-db.org/).
Transcriptomic analysis
Corneal endothelium was stripped and collected either from patient 
eyes with bullous keratopathy during EK or from Eye Bank eyes 
(SightLife, Seattle, WA, USA). In both procedures, the endothelium 
is routinely discarded. The removed endothelium was immediately 
submerged in TRIzol (15596-026, ThermoFisher Scientific) in ribo-
nuclease (RNase)–free 1.7-ml Eppendorf tubes and subsequently used 
for RNA-seq. The miRNeasy Micro Kit (Qiagen, Valencia, CA, 
USA) was used to extract tissue RNA, following the manufacturer’s 
instruction. RNA quality was checked using a NanoDrop (Thermo 
Fisher Scientific) and Bioanalyzer RNA 6000 pico chip (Agilent). 
Samples with RIN values above 6 were chosen for further analysis. 
Twelve samples were used for RNA-seq including seven bullous 
keratopathy and four healthy controls (table S5). RNA samples 
were prepared using the NEBNext Ultra II Directional RNA Library 
Prep Kit for Illumina (New England Biolabs Inc., Ipswich, MA, 
USA). The libraries were sequenced on a NextSeq (Illumina, 
San Diego, CA, USA) using a 75–base pair (bp) paired-end read high 
output v2 run. This produced 20 to 25 M paired-end reads per sample. 
We mapped the 75 nucleotide reads to human genome (University 
of California Santa Cruz Human hg19; https://genome.ucsc.edu/) using 
TopHat2 (ver 2.1.1; https://ccb.jhu.edu/software/tophat/index.shtml) 
and the Bowtie aligner (ver 2.3.2.0; http://bowtie-bio.sourceforge.
net/bowtie2/manual.shtml), allowing up to 2-bp mismatches per 
read (default position). StrandNGS (ver 3.2; www.strand-ngs.com/) 
was used to generate counts of reads uniquely mapped to known 
and annotated genes using RefSeqGene (2015.10.05; www.ncbi.
nlm.nih.gov/refseq/rsg/). A normalization factor was calculated 
using the trimmed mean of M values method, and the dispersion 
parameter for each gene was estimated with the Cox-Reid common 
dispersion method. Testing for differential expression used a negative 
binomial generalized linear model for each gene. The Benjamini- 
Hochberg correction was used to correct for multiple comparison 
with an FDR of 0.05. GO analysis was conducted using DAVID.
Animal experiment and transplantation surgery
This study adhered to the Association for Research in Vision and 
Ophthalmology statement for the Use of Animals in Ophthalmic and 
Vision Research. Six- to 20-week-old mice were purchased from Charles 
River Laboratories (Yokohama, Japan). We used 6- to 24-week-old 
BALBc mice (H-2d, Igh-Ca, CD52, and CD8a2), C57BL/6 mice 
(H-2b, Qa-1b, and Ly-92), and DBA2 (H-2d, Igh-Cc, CD51, and 
CD8a1). The donors and recipients represented minor antigen 
disparities in BALBc/DBA2J transplantation and minor antigen/
major histocompatibility complex disparities in C57BL6/DBA2J 
transplantation. Each animal was deeply anesthetized with an intra-
peritoneal injection of medetomidine (0.15 mg/kg), midazolam 
(2 mg/kg), and butorphanol (2.5 mg/kg) before surgical procedures. 
Endothelial lamellar keratoplasty were performed as reported pre-
viously (25). Briefly, after complete removal of corneal epithelium 
by scraping, central corneas from normal eyes of DBA2J and BALBc 
donors were excised and cut using Vannas Scissors (Inami Inc., 
Tokyo, Japan) into wedge-shaped fragments measuring approximately 
0.4 mm × 1.5 mm. Individual fragments were then inserted into the 
anterior chamber through an oblique incision and placed onto the 
center of the recipient endothelium by injecting a small air bubble. 
The mice with decentered or iris-touched grafts were excluded. 
Fourteen days after the procedure, corneas were excised for immuno-
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and JC-1 imaging analyses. Intraocular pressure in mice was 
measured using TonoLab (Icare Finland Oy, Vantaa, Finland) 
under general anesthesia.
Protein/cytokine measurement and hematoxylin and eosin 
stain of cellular aggregates in AqH
Human AqH samples were collected at the beginning of surgeries 
under sterile conditions using a 27-gauge needle. A total of 100 to 
200 l of AqH were stored in silicon-coated Eppendorf tubing after 
centrifuging at 3000 rpm for 5 min. In mouse experiments, approx-
imately 30 l of AqH samples was collected using a 27-gauge needle 
through an oblique incision from 10 to 12 mice. AqH from mouse 
eyes were centrifuged at 3000 rpm for 5 min, and supernatants were 
diluted with distilled water up to 160 l. Cellular aggregates were 
collected, and the cell smears were prepared on silane-coated slides 
(Muto Pure Chemicals Co., Ltd., Tokyo, Japan) using an Auto 
Smear CF-12C (Sakura, Tokyo, Japan) for hematoxylin and eosin stain 
(131-09665, Wako Pure Chemical Industries, Ltd., Osaka, Japan). 
For immunohistochemical evaluation in immune cells, the samples 
were fixed overnight in 10% neutral-buffered formalin, followed by 
heat-induced epitope retrieval that was performed at 121°C for 
10 min in 10 mM citrate buffer (pH 6.0). Immunocytochemistry 
was performed with rabbit anti-MPO antibody (Dako, Glostrup, 
Denmark) and mouse monoclonal anti-CD10 antibody (56C6) 
(Nichirei, Tokyo, Japan) and visualized by Alexa Fluor 594 anti- 
rabbit secondary antibody (Thermo Fisher Scientific) and Alexa 
Fluor 488 anti-mouse secondary antibody (Thermo Fisher Scientific), 
respectively. Healthy and posttransplanted corneas/iris tissues of 
DBA2J and BALBc mice were excised on postoperative day 14 (n = 
10 to 12 corneas per group). Corneas and iris tissues were washed 
and homogenized using a microhomogenizer (Kontes RNase-Free 
pellet pestle grinder, VWR, Radnor, PA, USA) in 150 l of phosphate- 
buffered saline (PBS), followed by centrifugation at 15,000 rpm for 
12 min at 4°C. Supernatants were diluted to 200 l and separated 
into 40 l (for protein concentration assay) and 160 l (for cytokine 
assay). All samples were stored at −80°C until the measurement. 
Protein concentrations were measured using the DC protein assay 
(Bio-Rad Lab, Hercules, CA, USA). For cytokine measurement in 
human samples, the levels of IL-1, IL-1, IL-4, IL-6, IL-8, IL-10, 
IL-12p70, IL-13, IL-17A, IFN-, IFN-, MCP-1, tumor necrosis 
factor– (TNF-), E-selectin, P-selectin, sICAM-1, macrophage 
inflammatory protein (MIP)–1, MIP-1, and IP-10 in AqH samples 
were measured using the Luminex (EPX200-12185-901, ProcartaPlex 
Human panel, Luminex, San Antonio, TX, USA) bead-based multiplex 
immunoassay according to previous reports without dilution (9). For 
cytokine measurement in mice, AqH samples were triplicated and 
the levels of IL-1, IL-2, IL-4, IL-5, IL-6, IL-8, IL-12p70, IL-13, IL-17A, 
IL-18, and IFN. Granulocyte-macrophage colony-stimulating 
factor, TNF-, MCP-1, and LIF were measured using Luminex 
(TFA-EPX110-20820-901 Mouse Th1/2 panel/MCP-1/LIF/IL-17A 
panel, Thermo Fisher Scientific). Cytokine levels in the iris and cor-
neas were standardized using known protein concentrations.
Immunohistological evaluation
Freshly excised corneas were washed in PBS and fixated in acetone 
(ZO-1) or 2% formaldehyde (8-OHdG) for 15 min on ice. To block 
nonspecific staining, corneas were incubated in 3% normal donkey 
serum (S30-100ML, Chemicon, Temecula, CA, USA), 1% bovine 
serum albumin (A-7030, Sigma-Aldrich, St. Louis, MO, USA), and 
0.3% Triton X-100 (9002-93-1, Sigma-Aldrich) for permeabilization 
of cell membrane (8-OHDG) for 1 hour at room temperature (RT). 
Corneas were then stained with conjugated anti–ZO-1 antibody 
(1:100; Thermo Fisher Scientific) or anti–8-OHdG antibody (1:100; 
JACI, Nagoya, Japan) at 4°C overnight, followed by incubation with 
rhodamine-conjugated secondary antibody (8-OHdG) for 30 min 
at RT. Each step was followed by three thorough 5-min PBS washes. 
For nuclei staining, corneal whole mounts were incubated with 
4′,6-diamidino-2-phenylindole (0.5 g/ml; Dojindo Laboratories, Tokyo, 
Japan) for 5 min at RT. Corneal whole mounts were prepared using 
an aqueous mounting medium containing an anti-fading agent 
(Fluoromount/Plus, Diagnostic BioSystems, Pleasanton, CA, USA). 
Specimen slides were observed under a florescence microscope 
(Axioplan 2 imaging, Carl Zeiss Inc., Thornwood, NY, USA).
Statistical analyses
Data were analyzed using Prism for Windows software (version 6.04, 
Graphpad Software Inc., San Diego, CA, USA). The D’Agostino 
and Pearson omnibus normality test was used to assess whether 
data showed a normal distribution. Spearman’s correlation analyses 
were used to evaluate the correlations among AqH protein levels 
and CECD. We conducted Cox proportional hazard model using 
STATA/IC 14.0 for Windows (StataCorp LP, College Station, TX) 
to assess the clinical factors that were associated with graft failure 
after corneal transplantation. We selected clinical factors (preoperative 
AqH protein level, the presence of glaucoma, preoperative steroid 
use, donor/recipient age, and donor CECD) as independent variables. 
AqH protein levels of ≥1.0 mg/ml, the presence of glaucoma, and 
preoperative steroid use were dichotomized as independent variables 
(variance inflation factors = 1.14 to 1.16). To compare differences in 
protein levels across groups, unpaired Student’s t test was used. 
Data are expressed as means ± SD. To compare differences in protein 
levels across groups in proteome analysis, moderated t test based on 
empirical Bayes approach was used (40). P < 0.05 was considered to 
be statistically significant. Cytokine data were also controlled with 
Bonferroni correction. Because there were 15 to 20 different com-
parisons (1 protein and 19 cytokines in human and 15 cytokines in 
mouse), P < 0.0025 (i.e., P = 0.05/20) was considered to be statisti-
cally significant after Bonferroni correction.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/6/20/eaaz5195/DC1
View/request a protocol for this paper from Bio-protocol.
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